1 hr ago
Statin May Slow Progression of Multiple Sclerosis
Results of a phase II study published in The Lancet suggest that simvastatin, a generic cholesterol-lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis , which is currently untreatable.
Trending on the Topix Network
5 hrs ago
Four must eat white vegetables
New York, April 18: If white coloured clothes have a soothing effect on people, eating white vegetables is beneficial too and you should include more of cauliflower and garlic in your diet.
9 hrs ago
Bakery & Snacks
An effective strategy for public cardio-metabolic health promotion?...
Using resistant starch-enriched flour in place of regular flour may reduce cholesterol levels in people with metabolic syndrome, report researchers from South Dakota State University.
Thu Apr 17, 2014
Lipids in Health and Disease
Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia
Inflammation and endothelial dysfunction is implicated in the atherosclerosis initiation and progression in the setting of hyperlipidemia.
Tue Apr 15, 2014
Prescription Drug Spending Climbs In 2013
Total U.S. prescription drug spending climbed more than 3 percent last year, propelled in part by fewer patent expirations that would have allowed for cheaper generic alternatives, according to the data firm IMS Health.
Pharmacist-led interventions show high success rates for post-stroke care
A new study from the Faculty of Medicine & Dentistry is looking at nurse- and pharmacist-led interventions to improve the standard of care for patients who have suffered minor stroke or transient ischemic attack, also known as "mini stoke."
Mon Apr 14, 2014
From Taiwan, A Long Hoped-For Breakthrough In The Fight Against Alzheimer's
Six Taiwan-based scientists have announced what may be a long hoped-for breakthrough in the fight against Alzheimer's disease.
Sun Apr 13, 2014
Two Things You Must Know About Pfizer
One of the world's largest research-based pharmaceutical company, Pfizer , is providing the public with a feeling of irony.
The Motley Fool
The Cost to Treat Cholesterol Plummets, But Will It Last?
Every year, Express Scripts crunches the previous year's data to uncover payer spending trends.
Sat Apr 12, 2014
Novartis overtakes Pfizer as top drug company
A robust sales year for three of Novartis' medications allowed the firm to pass reeling Pfizer for the top spot on Modern Healthcare's annual list of largest publicly traded pharmaceutical companies .
Fri Apr 11, 2014
Some medications have side effects of sexual dysfunction
Q: Doctors rarely if ever tell patients about sexual side effects of medication.
Wed Apr 09, 2014
Data on Simvastatin Therapy Discussed by Researchers at University of Lisbon
However, low aqueous solubility of crystalline statins and, consequently, reduced biovailability require seeking for alternative forms and formulations to ensure an accurate therapeutic window."
The Motley Fool
More Trouble Looming for Amarin Corporation?
Almost immediately after inking a co-promotional deal for the company's lone commercial product, Vascepa, with Kowa Pharmaceuticals America, Teva Pharmaceuticals announced yesterday they are launching a generic version of Lovaza.
Aegerion starts Japanese Phase III trial of cholesterol drug
Aegerion Pharmaceuticals has started a Phase 3 Trial in Japan to evaluate its Lomitapide treatment for cutting low-density lipoprotein cholesterol in patients with homozygous familial hypercholesterolemia .
Tue Apr 08, 2014
Lipitor could be sold over the counter
Right now, Lipitor is only available with a prescription and requires a doctor to monitor a patient's blood cholesterol levels and side effects.
Mon Apr 07, 2014
Ranbaxy bathes in Sunshine
Mumbai, April 7: Anlysts believe Sun Pharma owner Dilip Shanghvi possesses the Midas touch to turn around Ranbaxy, especially its travails in the US on quality issues.
Are cardiologists refusing to follow new cholesterol recommendations?
Criticism over new cholesterol treatment recommendations appears to be growing, judging by remarks made by cardiologists last week at the annual meeting of the American College of Cardiology, the group that issued the new guideline last November along with the American Heart Association.
Sun Apr 06, 2014
Marin Independent Journal
Dr. Bill Elliott: New guidelines downplay cholesterol levels
THE PAST 12 MONTHS have been quite eventful for those of us who practice in primary care.
Fri Apr 04, 2014
Half of U.S. adults ages 40 to 75 are eligible for cholesterol-lowering drugs
This 2011 photo provided by Watson Pharmaceuticals Inc. shows bottles of Atorvastatin calcium tablets, a generic form of Lipitor that is sold under a deal with Pfizer.
[Research Article] Structure of a Class C GPCR Metabotropic Glutamate ...
G protein-coupled receptors are membrane proteins that transduce extracellular signals to activate diverse signaling pathways.